NASDAQ:RCM R1 RCM (RCM) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free RCM Stock Alerts $12.45 -0.31 (-2.43%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$12.44▼$12.7950-Day Range$11.75▼$14.3952-Week Range$8.87▼$18.70Volume2.07 million shsAverage Volume3.45 million shsMarket Capitalization$5.24 billionP/E RatioN/ADividend YieldN/APrice Target$16.87 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get R1 RCM alerts: Email Address R1 RCM MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.62 Rating ScoreUpside/Downside34.8% Upside$16.79 Price TargetShort InterestHealthy7.34% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.61Based on 14 Articles This WeekInsider TradingSelling Shares$143,959 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.05) to $0.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.82 out of 5 starsBusiness Services Sector13th out of 313 stocksManagement Services Industry1st out of 5 stocks 4.3 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.62, and is based on 8 buy ratings, 5 hold ratings, and no sell ratings.Amount of Analyst CoverageR1 RCM has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about R1 RCM's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted7.34% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in R1 RCM has recently decreased by 7.69%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 2.6 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.36 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 14 news articles for R1 RCM this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for RCM on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $143,959.00 in company stock.Percentage Held by Insiders36.80% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about R1 RCM's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow in the coming year, from ($0.05) to $0.15 per share.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about R1 RCM's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About R1 RCM Stock (NASDAQ:RCM)R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.Read More RCM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCM Stock News HeadlinesMay 8, 2024 | globenewswire.comR1 RCM Reports First Quarter 2024 ResultsMay 7, 2024 | msn.comR1 RCM gains after granting waiver for takeover offerMay 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.May 5, 2024 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 3, 2024 | americanbankingnews.comQ1 2024 Earnings Estimate for R1 RCM Inc. Issued By Leerink Partnrs (NASDAQ:RCM)May 2, 2024 | americanbankingnews.comLeerink Partnrs Comments on R1 RCM Inc.'s Q2 2024 Earnings (NASDAQ:RCM)May 1, 2024 | americanbankingnews.comR1 RCM (RCM) to Release Quarterly Earnings on WednesdayApril 30, 2024 | msn.comR1 RCM may see $15 a share in LBO; deal looks more likely nowMay 8, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 30, 2024 | globenewswire.comR1 RCM to Present at the 2024 Bank of America Securities Health Care ConferenceApril 29, 2024 | za.investing.comRCM stock jumps as Jefferies sees a 20% take-private premiumApril 29, 2024 | marketwatch.comR1 RCM Holder New Mountain Pushes For Joint Buyout With TCP-ASCApril 25, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Buy Rating on Icon (ICLR)April 23, 2024 | finance.yahoo.comMedical Billing Outsourcing Market to USD 41.9Bn by 2032, says Global Market Insights Inc.April 18, 2024 | bbc.co.ukSit Down Stand Up Olympian SpecialApril 9, 2024 | fxstreet.comEUR/USD holds above 1.0860, eyes on US CPI, ECB rate decisionApril 8, 2024 | axios.comVista takes Model N private for $1.25BApril 4, 2024 | finance.yahoo.comInbox Health Announces Appointment of Kent Ivanoff to Board of DirectorsApril 3, 2024 | finance.yahoo.comCapstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial OfficerApril 1, 2024 | globenewswire.comR1 RCM to Release First Quarter 2024 Results on May 8, 2024April 1, 2024 | markets.businessinsider.comTruist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)March 27, 2024 | globenewswire.comR1 Releases Fourth Annual Environmental, Social and Governance (ESG) ReportMarch 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for R1 RCM Amid Strong Fundamentals and Prospective AcquisitionMarch 20, 2024 | msn.comR1 RCM pushes sales process forward, hiring bankersMarch 20, 2024 | msn.comR1 RCM gains amid Citi upgrade as deal still likely to happenMarch 20, 2024 | markets.businessinsider.comAnalyst Scoreboard: 12 Ratings For R1 RCMMarch 19, 2024 | wsj.comR1 RCM Tells Two Top Holders to End Buyout TalksSee More Headlines Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/16/2023Today5/07/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Management services Sub-IndustryHealth Care Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees30,000Year Founded2003Price Target and Rating Average Stock Price Target$16.87 High Stock Price Target$22.00 Low Stock Price Target$11.00 Potential Upside/Downside+35.5%Consensus RatingModerate Buy Rating Score (0-4)2.62 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.30 million Net Margins0.15% Pretax Margin0.93% Return on Equity0.12% Return on Assets0.07% Debt Debt-to-Equity Ratio0.57 Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$2.25 billion Price / Sales2.32 Cash Flow$0.68 per share Price / Cash Flow18.20 Book Value$6.56 per share Price / Book1.90Miscellaneous Outstanding Shares420,730,000Free Float265,901,000Market Cap$5.24 billion OptionableOptionable Beta0.78 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Lee Rivas (Age 49)CEO & Director Comp: $1.92MMr. John M. Sparby (Age 48)President Comp: $1.46MMs. Jennifer Williams (Age 47)Executive VP, CFO & Treasurer Comp: $1.13MKey CompetitorsAurora InnovationNASDAQ:AURTriNet GroupNYSE:TNETMaximusNYSE:MMSShift4 PaymentsNYSE:FOURFirstCashNASDAQ:FCFSView All CompetitorsInsiders & InstitutionsQRG Capital Management Inc.Bought 10,227 shares on 5/8/2024Ownership: 0.002%Texas Permanent School Fund CorpBought 2,135 shares on 5/6/2024Ownership: 0.041%BW Gestao de Investimentos Ltda.Bought 893,896 shares on 5/2/2024Ownership: 0.212%Mutual of America Capital Management LLCSold 3,525 shares on 5/2/2024Ownership: 0.028%Fifth Lane Capital LPBought 40,900 shares on 5/2/2024Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions RCM Stock Analysis - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price target for 2024? 13 Wall Street research analysts have issued 1 year target prices for R1 RCM's stock. Their RCM share price targets range from $11.00 to $22.00. On average, they anticipate the company's stock price to reach $16.79 in the next year. This suggests a possible upside of 34.8% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2024? R1 RCM's stock was trading at $10.57 at the beginning of the year. Since then, RCM shares have increased by 17.8% and is now trading at $12.45. View the best growth stocks for 2024 here. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our RCM earnings forecast. How can I listen to R1 RCM's earnings call? R1 RCM will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) released its earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a trailing twelve-month return on equity of 0.12% and a net margin of 0.15%. R1 RCM's revenue was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.11 earnings per share. What ETFs hold R1 RCM's stock? ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT) and SPDR S&P Health Care Services ETF (XHS).iShares U.S. Healthcare Providers ETF (IHF). What guidance has R1 RCM issued on next quarter's earnings? R1 RCM issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.6 billion-$2.6 billion, compared to the consensus revenue estimate of $2.6 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). Who are R1 RCM's major shareholders? R1 RCM's stock is owned by a number of institutional and retail investors. Top institutional investors include BW Gestao de Investimentos Ltda. (0.21%), Principal Financial Group Inc. (0.18%), Mirae Asset Global Investments Co. Ltd. (0.09%), Retirement Systems of Alabama (0.06%), Texas Permanent School Fund Corp (0.04%) and New York State Teachers Retirement System (0.03%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More This page (NASDAQ:RCM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
